Page last updated: 2024-11-12

bms-566394

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

BMS-566394: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11294179
CHEMBL ID253275
SCHEMBL ID6790471
MeSH IDM0522532

Synonyms (10)

Synonym
(3r,4r)-3-n-hydroxy-4-n-(4-{[2-(trifluoromethyl)-1h-1,3-benzodiazol-1-yl]methyl}benzene)oxane-3,4-diamido
chembl253275 ,
bdbm26806
bms-566394
SCHEMBL6790471
503166-51-6
2h-pyran-3-carboxamide, tetrahydro-n-hydroxy-4-[[4-[[2-(trifluoromethyl)-1h-benzimidazol-1-yl]methyl]benzoyl]amino]-, (3r,4r)-
2h-pyran-3-carboxamide,tetrahydro-n-hydroxy-4-[[4-[[2-(trifluoromethyl)-1h-benzimidazol-1-yl]methyl]benzoyl]amino]-,(3r,4r)-
(3r,4r)-n-hydroxy-4-[[4-[[2-(trifluoromethyl)benzimidazol-1-yl]methyl]benzoyl]amino]oxane-3-carboxamide
pgvyypzkxkgbld-jksujkdbsa-n
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (17)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
A disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)Ki6.70006.70006.70006.7000AID314349; AID344623
Disintegrin and metalloproteinase domain-containing protein 17Sus scrofa (pig)IC50 (µMol)2.00100.00101.33658.0000AID1798732; AID314333; AID344653
Interstitial collagenaseHomo sapiens (human)Ki7.47400.00030.49487.0000AID314335; AID349373
72 kDa type IV collagenaseHomo sapiens (human)Ki6.66650.00000.34663.0000AID314336; AID349374
Stromelysin-1Homo sapiens (human)IC50 (µMol)4.00070.00001.148410.0000AID1798732
Stromelysin-1Homo sapiens (human)Ki10.00000.00030.54258.0000AID314339; AID349375
MatrilysinHomo sapiens (human)IC50 (µMol)4.00070.00142.085910.0000AID1798732
MatrilysinHomo sapiens (human)Ki10.00000.05401.50527.0000AID314340; AID349378
Stromelysin-2Homo sapiens (human)IC50 (µMol)7.00030.00052.875410.0000AID1798732; AID314342; AID349414
Matrix metalloproteinase-9Homo sapiens (human)Ki6.06400.00020.12810.8000AID314337; AID349379
Neutrophil collagenaseHomo sapiens (human)IC50 (µMol)4.00070.00000.927210.0000AID1798732
Neutrophil collagenaseHomo sapiens (human)Ki10.00000.00020.17972.1000AID314341; AID349376
Macrophage metalloelastaseHomo sapiens (human)IC50 (µMol)6.00030.00022.721710.0000AID1798732; AID314343; AID349385
Collagenase 3Homo sapiens (human)IC50 (µMol)4.00070.00000.767510.0000AID1798732
Collagenase 3Homo sapiens (human)Ki10.00000.00000.47593.8000AID314344; AID349377
Matrix metalloproteinase-14Homo sapiens (human)Ki10.00000.01400.06770.1100AID314345; AID349381
Matrix metalloproteinase-15Homo sapiens (human)Ki10.00003.99703.99703.9970AID349415
Matrix metalloproteinase-16Homo sapiens (human)Ki10.00001.59901.59901.5990AID314347; AID349413
A disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)Ki1.45001.00001.45001.9000AID314350; AID344624
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (159)

Processvia Protein(s)Taxonomy
membrane protein ectodomain proteolysisDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
negative regulation of gene expressionDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
in utero embryonic developmentDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
protein phosphorylationDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
membrane protein ectodomain proteolysisDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
negative regulation of cell adhesionDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
Notch signaling pathwayDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
integrin-mediated signaling pathwayDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
cell-cell signalingDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
positive regulation of cell population proliferationDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
regulation of Notch signaling pathwayDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
positive regulation of T cell chemotaxisDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
protein processingDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
extracellular matrix disassemblyDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
positive regulation of cell growthDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
positive regulation of cell migrationDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
adherens junction organizationDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
response to tumor necrosis factorDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
epidermal growth factor receptor ligand maturationDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
monocyte activationDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
pore complex assemblyDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
constitutive protein ectodomain proteolysisDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
cochlea developmentDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
regulation of neurotransmitter receptor localization to postsynaptic specialization membraneDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
postsynapse organizationDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
regulation of postsynapse organizationDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
protein catabolic process at postsynapseDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
regulation of vasculature developmentDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
skeletal system developmentA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
proteolysisA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
extracellular matrix disassemblyA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
extracellular matrix organizationA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
proteolysisInterstitial collagenaseHomo sapiens (human)
protein metabolic processInterstitial collagenaseHomo sapiens (human)
extracellular matrix disassemblyInterstitial collagenaseHomo sapiens (human)
collagen catabolic processInterstitial collagenaseHomo sapiens (human)
positive regulation of protein-containing complex assemblyInterstitial collagenaseHomo sapiens (human)
cellular response to UV-AInterstitial collagenaseHomo sapiens (human)
extracellular matrix organizationInterstitial collagenaseHomo sapiens (human)
angiogenesis72 kDa type IV collagenaseHomo sapiens (human)
ovarian follicle development72 kDa type IV collagenaseHomo sapiens (human)
ovulation from ovarian follicle72 kDa type IV collagenaseHomo sapiens (human)
luteinization72 kDa type IV collagenaseHomo sapiens (human)
blood vessel maturation72 kDa type IV collagenaseHomo sapiens (human)
intramembranous ossification72 kDa type IV collagenaseHomo sapiens (human)
proteolysis72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of cell adhesion72 kDa type IV collagenaseHomo sapiens (human)
heart development72 kDa type IV collagenaseHomo sapiens (human)
embryo implantation72 kDa type IV collagenaseHomo sapiens (human)
parturition72 kDa type IV collagenaseHomo sapiens (human)
response to xenobiotic stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to mechanical stimulus72 kDa type IV collagenaseHomo sapiens (human)
peripheral nervous system axon regeneration72 kDa type IV collagenaseHomo sapiens (human)
response to activity72 kDa type IV collagenaseHomo sapiens (human)
protein metabolic process72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix disassembly72 kDa type IV collagenaseHomo sapiens (human)
protein catabolic process72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of cell migration72 kDa type IV collagenaseHomo sapiens (human)
collagen catabolic process72 kDa type IV collagenaseHomo sapiens (human)
response to retinoic acid72 kDa type IV collagenaseHomo sapiens (human)
cellular response to reactive oxygen species72 kDa type IV collagenaseHomo sapiens (human)
response to nicotine72 kDa type IV collagenaseHomo sapiens (human)
endodermal cell differentiation72 kDa type IV collagenaseHomo sapiens (human)
response to hydrogen peroxide72 kDa type IV collagenaseHomo sapiens (human)
response to estrogen72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of vasoconstriction72 kDa type IV collagenaseHomo sapiens (human)
ephrin receptor signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
macrophage chemotaxis72 kDa type IV collagenaseHomo sapiens (human)
response to electrical stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to hyperoxia72 kDa type IV collagenaseHomo sapiens (human)
face morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
bone trabecula formation72 kDa type IV collagenaseHomo sapiens (human)
prostate gland epithelium morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
cellular response to amino acid stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to interleukin-172 kDa type IV collagenaseHomo sapiens (human)
cellular response to estradiol stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to UV-A72 kDa type IV collagenaseHomo sapiens (human)
cellular response to fluid shear stress72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
response to amyloid-beta72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix organization72 kDa type IV collagenaseHomo sapiens (human)
response to hypoxia72 kDa type IV collagenaseHomo sapiens (human)
tissue remodeling72 kDa type IV collagenaseHomo sapiens (human)
proteolysisStromelysin-1Homo sapiens (human)
extracellular matrix disassemblyStromelysin-1Homo sapiens (human)
protein catabolic processStromelysin-1Homo sapiens (human)
regulation of cell migrationStromelysin-1Homo sapiens (human)
collagen catabolic processStromelysin-1Homo sapiens (human)
positive regulation of protein-containing complex assemblyStromelysin-1Homo sapiens (human)
cellular response to reactive oxygen speciesStromelysin-1Homo sapiens (human)
innate immune responseStromelysin-1Homo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionStromelysin-1Homo sapiens (human)
cellular response to lipopolysaccharideStromelysin-1Homo sapiens (human)
cellular response to amino acid stimulusStromelysin-1Homo sapiens (human)
cellular response to UV-AStromelysin-1Homo sapiens (human)
cellular response to nitric oxideStromelysin-1Homo sapiens (human)
regulation of neuroinflammatory responseStromelysin-1Homo sapiens (human)
response to amyloid-betaStromelysin-1Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processStromelysin-1Homo sapiens (human)
extracellular matrix organizationStromelysin-1Homo sapiens (human)
membrane protein ectodomain proteolysisMatrilysinHomo sapiens (human)
membrane protein intracellular domain proteolysisMatrilysinHomo sapiens (human)
antibacterial peptide secretionMatrilysinHomo sapiens (human)
antibacterial peptide biosynthetic processMatrilysinHomo sapiens (human)
proteolysisMatrilysinHomo sapiens (human)
response to xenobiotic stimulusMatrilysinHomo sapiens (human)
extracellular matrix disassemblyMatrilysinHomo sapiens (human)
positive regulation of cell migrationMatrilysinHomo sapiens (human)
collagen catabolic processMatrilysinHomo sapiens (human)
regulation of cell population proliferationMatrilysinHomo sapiens (human)
defense response to Gram-negative bacteriumMatrilysinHomo sapiens (human)
defense response to Gram-positive bacteriumMatrilysinHomo sapiens (human)
extracellular matrix organizationMatrilysinHomo sapiens (human)
proteolysisStromelysin-2Homo sapiens (human)
extracellular matrix disassemblyStromelysin-2Homo sapiens (human)
collagen catabolic processStromelysin-2Homo sapiens (human)
extracellular matrix organizationStromelysin-2Homo sapiens (human)
skeletal system developmentMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of protein phosphorylationMatrix metalloproteinase-9Homo sapiens (human)
proteolysisMatrix metalloproteinase-9Homo sapiens (human)
apoptotic processMatrix metalloproteinase-9Homo sapiens (human)
embryo implantationMatrix metalloproteinase-9Homo sapiens (human)
cell migrationMatrix metalloproteinase-9Homo sapiens (human)
extracellular matrix disassemblyMatrix metalloproteinase-9Homo sapiens (human)
macrophage differentiationMatrix metalloproteinase-9Homo sapiens (human)
collagen catabolic processMatrix metalloproteinase-9Homo sapiens (human)
cellular response to reactive oxygen speciesMatrix metalloproteinase-9Homo sapiens (human)
endodermal cell differentiationMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of apoptotic processMatrix metalloproteinase-9Homo sapiens (human)
negative regulation of apoptotic processMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of DNA bindingMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayMatrix metalloproteinase-9Homo sapiens (human)
ephrin receptor signaling pathwayMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of keratinocyte migrationMatrix metalloproteinase-9Homo sapiens (human)
cellular response to lipopolysaccharideMatrix metalloproteinase-9Homo sapiens (human)
cellular response to cadmium ionMatrix metalloproteinase-9Homo sapiens (human)
cellular response to UV-AMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaMatrix metalloproteinase-9Homo sapiens (human)
regulation of neuroinflammatory responseMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of receptor bindingMatrix metalloproteinase-9Homo sapiens (human)
response to amyloid-betaMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationMatrix metalloproteinase-9Homo sapiens (human)
negative regulation of epithelial cell differentiation involved in kidney developmentMatrix metalloproteinase-9Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathwayMatrix metalloproteinase-9Homo sapiens (human)
negative regulation of cation channel activityMatrix metalloproteinase-9Homo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathwayMatrix metalloproteinase-9Homo sapiens (human)
extracellular matrix organizationMatrix metalloproteinase-9Homo sapiens (human)
positive regulation of microglial cell activationNeutrophil collagenaseHomo sapiens (human)
proteolysisNeutrophil collagenaseHomo sapiens (human)
extracellular matrix disassemblyNeutrophil collagenaseHomo sapiens (human)
collagen catabolic processNeutrophil collagenaseHomo sapiens (human)
positive regulation of tumor necrosis factor productionNeutrophil collagenaseHomo sapiens (human)
endodermal cell differentiationNeutrophil collagenaseHomo sapiens (human)
cellular response to lipopolysaccharideNeutrophil collagenaseHomo sapiens (human)
positive regulation of neuroinflammatory responseNeutrophil collagenaseHomo sapiens (human)
positive regulation of tumor necrosis factor-mediated signaling pathwayNeutrophil collagenaseHomo sapiens (human)
extracellular matrix organizationNeutrophil collagenaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIMacrophage metalloelastaseHomo sapiens (human)
proteolysisMacrophage metalloelastaseHomo sapiens (human)
protein import into nucleusMacrophage metalloelastaseHomo sapiens (human)
extracellular matrix disassemblyMacrophage metalloelastaseHomo sapiens (human)
collagen catabolic processMacrophage metalloelastaseHomo sapiens (human)
positive regulation of interferon-alpha productionMacrophage metalloelastaseHomo sapiens (human)
wound healing, spreading of epidermal cellsMacrophage metalloelastaseHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIMacrophage metalloelastaseHomo sapiens (human)
lung alveolus developmentMacrophage metalloelastaseHomo sapiens (human)
regulation of defense response to virus by hostMacrophage metalloelastaseHomo sapiens (human)
positive regulation of epithelial cell proliferation involved in wound healingMacrophage metalloelastaseHomo sapiens (human)
elastin catabolic processMacrophage metalloelastaseHomo sapiens (human)
negative regulation of type I interferon-mediated signaling pathwayMacrophage metalloelastaseHomo sapiens (human)
positive regulation of type I interferon-mediated signaling pathwayMacrophage metalloelastaseHomo sapiens (human)
bronchiole developmentMacrophage metalloelastaseHomo sapiens (human)
cellular response to virusMacrophage metalloelastaseHomo sapiens (human)
response to amyloid-betaMacrophage metalloelastaseHomo sapiens (human)
negative regulation of endothelial cell-matrix adhesion via fibronectinMacrophage metalloelastaseHomo sapiens (human)
extracellular matrix organizationMacrophage metalloelastaseHomo sapiens (human)
endochondral ossificationCollagenase 3Homo sapiens (human)
growth plate cartilage developmentCollagenase 3Homo sapiens (human)
proteolysisCollagenase 3Homo sapiens (human)
extracellular matrix disassemblyCollagenase 3Homo sapiens (human)
bone mineralizationCollagenase 3Homo sapiens (human)
collagen catabolic processCollagenase 3Homo sapiens (human)
bone morphogenesisCollagenase 3Homo sapiens (human)
response to amyloid-betaCollagenase 3Homo sapiens (human)
extracellular matrix organizationCollagenase 3Homo sapiens (human)
angiogenesisMatrix metalloproteinase-14Homo sapiens (human)
ovarian follicle developmentMatrix metalloproteinase-14Homo sapiens (human)
response to hypoxiaMatrix metalloproteinase-14Homo sapiens (human)
endothelial cell proliferationMatrix metalloproteinase-14Homo sapiens (human)
endochondral ossificationMatrix metalloproteinase-14Homo sapiens (human)
proteolysisMatrix metalloproteinase-14Homo sapiens (human)
response to oxidative stressMatrix metalloproteinase-14Homo sapiens (human)
male gonad developmentMatrix metalloproteinase-14Homo sapiens (human)
response to mechanical stimulusMatrix metalloproteinase-14Homo sapiens (human)
positive regulation of myotube differentiationMatrix metalloproteinase-14Homo sapiens (human)
positive regulation of protein processingMatrix metalloproteinase-14Homo sapiens (human)
response to organic cyclic compoundMatrix metalloproteinase-14Homo sapiens (human)
protein processingMatrix metalloproteinase-14Homo sapiens (human)
extracellular matrix disassemblyMatrix metalloproteinase-14Homo sapiens (human)
protein catabolic processMatrix metalloproteinase-14Homo sapiens (human)
positive regulation of cell growthMatrix metalloproteinase-14Homo sapiens (human)
lung developmentMatrix metalloproteinase-14Homo sapiens (human)
positive regulation of cell migrationMatrix metalloproteinase-14Homo sapiens (human)
collagen catabolic processMatrix metalloproteinase-14Homo sapiens (human)
zymogen activationMatrix metalloproteinase-14Homo sapiens (human)
endodermal cell differentiationMatrix metalloproteinase-14Homo sapiens (human)
chondrocyte proliferationMatrix metalloproteinase-14Homo sapiens (human)
astrocyte cell migrationMatrix metalloproteinase-14Homo sapiens (human)
response to estrogenMatrix metalloproteinase-14Homo sapiens (human)
positive regulation of B cell differentiationMatrix metalloproteinase-14Homo sapiens (human)
negative regulation of Notch signaling pathwayMatrix metalloproteinase-14Homo sapiens (human)
embryonic cranial skeleton morphogenesisMatrix metalloproteinase-14Homo sapiens (human)
branching morphogenesis of an epithelial tubeMatrix metalloproteinase-14Homo sapiens (human)
tissue remodelingMatrix metalloproteinase-14Homo sapiens (human)
cell motilityMatrix metalloproteinase-14Homo sapiens (human)
negative regulation of focal adhesion assemblyMatrix metalloproteinase-14Homo sapiens (human)
head developmentMatrix metalloproteinase-14Homo sapiens (human)
craniofacial suture morphogenesisMatrix metalloproteinase-14Homo sapiens (human)
negative regulation of GDF15-GFRAL signaling pathwayMatrix metalloproteinase-14Homo sapiens (human)
regulation of protein localization to plasma membraneMatrix metalloproteinase-14Homo sapiens (human)
positive regulation of macrophage migrationMatrix metalloproteinase-14Homo sapiens (human)
response to odorantMatrix metalloproteinase-14Homo sapiens (human)
extracellular matrix organizationMatrix metalloproteinase-14Homo sapiens (human)
skeletal system developmentMatrix metalloproteinase-14Homo sapiens (human)
proteolysisMatrix metalloproteinase-15Homo sapiens (human)
extracellular matrix disassemblyMatrix metalloproteinase-15Homo sapiens (human)
collagen catabolic processMatrix metalloproteinase-15Homo sapiens (human)
response to estradiolMatrix metalloproteinase-15Homo sapiens (human)
endodermal cell differentiationMatrix metalloproteinase-15Homo sapiens (human)
protein modification processMatrix metalloproteinase-15Homo sapiens (human)
extracellular matrix organizationMatrix metalloproteinase-15Homo sapiens (human)
endochondral ossificationMatrix metalloproteinase-16Homo sapiens (human)
proteolysisMatrix metalloproteinase-16Homo sapiens (human)
protein processingMatrix metalloproteinase-16Homo sapiens (human)
chondrocyte proliferationMatrix metalloproteinase-16Homo sapiens (human)
embryonic cranial skeleton morphogenesisMatrix metalloproteinase-16Homo sapiens (human)
craniofacial suture morphogenesisMatrix metalloproteinase-16Homo sapiens (human)
skeletal system developmentMatrix metalloproteinase-16Homo sapiens (human)
extracellular matrix organizationMatrix metalloproteinase-16Homo sapiens (human)
collagen catabolic processMatrix metalloproteinase-16Homo sapiens (human)
negative regulation of angiogenesisA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
ovulation from ovarian follicleA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
kidney developmentA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
proteolysisA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
integrin-mediated signaling pathwayA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
negative regulation of cell population proliferationA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
heart trabecula formationA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell migrationA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
extracellular matrix organizationA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
aortic valve morphogenesisA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
pulmonary valve morphogenesisA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
endocardial cushion morphogenesisA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
proteolysisA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
myoblast fusionA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
extracellular matrix disassemblyA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
defense response to bacteriumA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
negative regulation of cold-induced thermogenesisA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
extracellular matrix organizationA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (28)

Processvia Protein(s)Taxonomy
endopeptidase activityDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
metalloendopeptidase activityDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
signaling receptor bindingDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
integrin bindingDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
protein bindingDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
metallopeptidase activityDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
SH3 domain bindingDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
protein kinase bindingDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
protein homodimerization activityDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
metal ion bindingDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
molecular adaptor activityDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
metallodipeptidase activityDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
metalloendopeptidase activity involved in amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
protease bindingA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
metalloendopeptidase activityA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
protein bindingA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
peptidase activityA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
metallopeptidase activityA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
zinc ion bindingA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
endopeptidase activityInterstitial collagenaseHomo sapiens (human)
metalloendopeptidase activityInterstitial collagenaseHomo sapiens (human)
serine-type endopeptidase activityInterstitial collagenaseHomo sapiens (human)
peptidase activityInterstitial collagenaseHomo sapiens (human)
zinc ion bindingInterstitial collagenaseHomo sapiens (human)
fibronectin binding72 kDa type IV collagenaseHomo sapiens (human)
endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
metalloendopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
serine-type endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
protein binding72 kDa type IV collagenaseHomo sapiens (human)
metallopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
zinc ion binding72 kDa type IV collagenaseHomo sapiens (human)
endopeptidase activityStromelysin-1Homo sapiens (human)
metalloendopeptidase activityStromelysin-1Homo sapiens (human)
serine-type endopeptidase activityStromelysin-1Homo sapiens (human)
protein bindingStromelysin-1Homo sapiens (human)
peptidase activityStromelysin-1Homo sapiens (human)
metallopeptidase activityStromelysin-1Homo sapiens (human)
zinc ion bindingStromelysin-1Homo sapiens (human)
endopeptidase activityMatrilysinHomo sapiens (human)
metalloendopeptidase activityMatrilysinHomo sapiens (human)
serine-type endopeptidase activityMatrilysinHomo sapiens (human)
protein bindingMatrilysinHomo sapiens (human)
metallopeptidase activityMatrilysinHomo sapiens (human)
zinc ion bindingMatrilysinHomo sapiens (human)
metalloendopeptidase activityStromelysin-2Homo sapiens (human)
serine-type endopeptidase activityStromelysin-2Homo sapiens (human)
zinc ion bindingStromelysin-2Homo sapiens (human)
endopeptidase activityMatrix metalloproteinase-9Homo sapiens (human)
metalloendopeptidase activityMatrix metalloproteinase-9Homo sapiens (human)
serine-type endopeptidase activityMatrix metalloproteinase-9Homo sapiens (human)
protein bindingMatrix metalloproteinase-9Homo sapiens (human)
collagen bindingMatrix metalloproteinase-9Homo sapiens (human)
peptidase activityMatrix metalloproteinase-9Homo sapiens (human)
metallopeptidase activityMatrix metalloproteinase-9Homo sapiens (human)
zinc ion bindingMatrix metalloproteinase-9Homo sapiens (human)
identical protein bindingMatrix metalloproteinase-9Homo sapiens (human)
endopeptidase activityNeutrophil collagenaseHomo sapiens (human)
metalloendopeptidase activityNeutrophil collagenaseHomo sapiens (human)
serine-type endopeptidase activityNeutrophil collagenaseHomo sapiens (human)
peptidase activityNeutrophil collagenaseHomo sapiens (human)
zinc ion bindingNeutrophil collagenaseHomo sapiens (human)
tumor necrosis factor bindingNeutrophil collagenaseHomo sapiens (human)
core promoter sequence-specific DNA bindingMacrophage metalloelastaseHomo sapiens (human)
endopeptidase activityMacrophage metalloelastaseHomo sapiens (human)
metalloendopeptidase activityMacrophage metalloelastaseHomo sapiens (human)
serine-type endopeptidase activityMacrophage metalloelastaseHomo sapiens (human)
calcium ion bindingMacrophage metalloelastaseHomo sapiens (human)
collagen bindingMacrophage metalloelastaseHomo sapiens (human)
zinc ion bindingMacrophage metalloelastaseHomo sapiens (human)
sequence-specific DNA bindingMacrophage metalloelastaseHomo sapiens (human)
endopeptidase activityCollagenase 3Homo sapiens (human)
metalloendopeptidase activityCollagenase 3Homo sapiens (human)
serine-type endopeptidase activityCollagenase 3Homo sapiens (human)
calcium ion bindingCollagenase 3Homo sapiens (human)
collagen bindingCollagenase 3Homo sapiens (human)
zinc ion bindingCollagenase 3Homo sapiens (human)
endopeptidase activityMatrix metalloproteinase-14Homo sapiens (human)
metalloendopeptidase activityMatrix metalloproteinase-14Homo sapiens (human)
serine-type endopeptidase activityMatrix metalloproteinase-14Homo sapiens (human)
integrin bindingMatrix metalloproteinase-14Homo sapiens (human)
protein bindingMatrix metalloproteinase-14Homo sapiens (human)
zinc ion bindingMatrix metalloproteinase-14Homo sapiens (human)
metalloaminopeptidase activityMatrix metalloproteinase-14Homo sapiens (human)
metalloendopeptidase activityMatrix metalloproteinase-15Homo sapiens (human)
protein bindingMatrix metalloproteinase-15Homo sapiens (human)
enzyme activator activityMatrix metalloproteinase-15Homo sapiens (human)
zinc ion bindingMatrix metalloproteinase-15Homo sapiens (human)
metalloaminopeptidase activityMatrix metalloproteinase-15Homo sapiens (human)
metalloendopeptidase activityMatrix metalloproteinase-16Homo sapiens (human)
enzyme activator activityMatrix metalloproteinase-16Homo sapiens (human)
zinc ion bindingMatrix metalloproteinase-16Homo sapiens (human)
metalloaminopeptidase activityMatrix metalloproteinase-16Homo sapiens (human)
metalloendopeptidase activityA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
protein bindingA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
heparin bindingA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
metallopeptidase activityA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
zinc ion bindingA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
endopeptidase activityA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
metalloendopeptidase activityA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
integrin bindingA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
protein bindingA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
heparin bindingA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
peptidase activityA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
metallopeptidase activityA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
zinc ion bindingA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
identical protein bindingA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
extracellular matrix bindingA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (41)

Processvia Protein(s)Taxonomy
Golgi membraneDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
nucleusDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
cytoplasmDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
endoplasmic reticulum lumenDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
Golgi apparatusDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
Golgi-associated vesicleDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
adherens junctionDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
focal adhesionDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
cell surfaceDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
postsynaptic densityDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
membraneDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
clathrin-coated vesicleDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
axonDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
dendriteDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
specific granule membraneDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
intracellular membrane-bounded organelleDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
extracellular exosomeDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
tertiary granule membraneDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
perinuclear endoplasmic reticulumDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
synaptic membraneDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
tetraspanin-enriched microdomainDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
glutamatergic synapseDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
pore complexDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
synaptic membraneDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 10Homo sapiens (human)
extracellular regionA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
extracellular spaceA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
nuclear speckA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
collagen-containing extracellular matrixA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
extracellular matrixA disintegrin and metalloproteinase with thrombospondin motifs 4Homo sapiens (human)
extracellular regionInterstitial collagenaseHomo sapiens (human)
extracellular matrixInterstitial collagenaseHomo sapiens (human)
extracellular spaceInterstitial collagenaseHomo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular region72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
nucleus72 kDa type IV collagenaseHomo sapiens (human)
mitochondrion72 kDa type IV collagenaseHomo sapiens (human)
plasma membrane72 kDa type IV collagenaseHomo sapiens (human)
sarcomere72 kDa type IV collagenaseHomo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
extracellular regionStromelysin-1Homo sapiens (human)
nucleusStromelysin-1Homo sapiens (human)
mitochondrionStromelysin-1Homo sapiens (human)
cytosolStromelysin-1Homo sapiens (human)
extracellular matrixStromelysin-1Homo sapiens (human)
extracellular spaceStromelysin-1Homo sapiens (human)
extracellular regionMatrilysinHomo sapiens (human)
extracellular matrixMatrilysinHomo sapiens (human)
extracellular exosomeMatrilysinHomo sapiens (human)
extracellular spaceMatrilysinHomo sapiens (human)
extracellular regionStromelysin-2Homo sapiens (human)
extracellular matrixStromelysin-2Homo sapiens (human)
extracellular spaceStromelysin-2Homo sapiens (human)
extracellular regionMatrix metalloproteinase-9Homo sapiens (human)
extracellular spaceMatrix metalloproteinase-9Homo sapiens (human)
collagen-containing extracellular matrixMatrix metalloproteinase-9Homo sapiens (human)
extracellular exosomeMatrix metalloproteinase-9Homo sapiens (human)
tertiary granule lumenMatrix metalloproteinase-9Homo sapiens (human)
ficolin-1-rich granule lumenMatrix metalloproteinase-9Homo sapiens (human)
extracellular spaceMatrix metalloproteinase-9Homo sapiens (human)
extracellular regionNeutrophil collagenaseHomo sapiens (human)
extracellular spaceNeutrophil collagenaseHomo sapiens (human)
specific granule lumenNeutrophil collagenaseHomo sapiens (human)
collagen-containing extracellular matrixNeutrophil collagenaseHomo sapiens (human)
tertiary granule lumenNeutrophil collagenaseHomo sapiens (human)
extracellular spaceNeutrophil collagenaseHomo sapiens (human)
extracellular regionMacrophage metalloelastaseHomo sapiens (human)
extracellular spaceMacrophage metalloelastaseHomo sapiens (human)
nucleusMacrophage metalloelastaseHomo sapiens (human)
cytoplasmMacrophage metalloelastaseHomo sapiens (human)
extracellular matrixMacrophage metalloelastaseHomo sapiens (human)
extracellular spaceMacrophage metalloelastaseHomo sapiens (human)
extracellular regionCollagenase 3Homo sapiens (human)
extracellular matrixCollagenase 3Homo sapiens (human)
extracellular spaceCollagenase 3Homo sapiens (human)
cytoplasmMatrix metalloproteinase-14Homo sapiens (human)
plasma membraneMatrix metalloproteinase-14Homo sapiens (human)
extracellular spaceMatrix metalloproteinase-14Homo sapiens (human)
nucleusMatrix metalloproteinase-14Homo sapiens (human)
Golgi lumenMatrix metalloproteinase-14Homo sapiens (human)
cytosolMatrix metalloproteinase-14Homo sapiens (human)
plasma membraneMatrix metalloproteinase-14Homo sapiens (human)
focal adhesionMatrix metalloproteinase-14Homo sapiens (human)
extracellular matrixMatrix metalloproteinase-14Homo sapiens (human)
cytoplasmic vesicleMatrix metalloproteinase-14Homo sapiens (human)
melanosomeMatrix metalloproteinase-14Homo sapiens (human)
macropinosomeMatrix metalloproteinase-14Homo sapiens (human)
intermediate filament cytoskeletonMatrix metalloproteinase-14Homo sapiens (human)
extracellular spaceMatrix metalloproteinase-14Homo sapiens (human)
plasma membraneMatrix metalloproteinase-15Homo sapiens (human)
extracellular matrixMatrix metalloproteinase-15Homo sapiens (human)
extracellular spaceMatrix metalloproteinase-15Homo sapiens (human)
Golgi lumenMatrix metalloproteinase-16Homo sapiens (human)
plasma membraneMatrix metalloproteinase-16Homo sapiens (human)
cell surfaceMatrix metalloproteinase-16Homo sapiens (human)
extracellular matrixMatrix metalloproteinase-16Homo sapiens (human)
plasma membraneMatrix metalloproteinase-16Homo sapiens (human)
extracellular spaceMatrix metalloproteinase-16Homo sapiens (human)
collagen-containing extracellular matrixA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
extracellular regionA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
basement membraneA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
cytoplasmic vesicleA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
extracellular matrixA disintegrin and metalloproteinase with thrombospondin motifs 1Homo sapiens (human)
extracellular regionA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
extracellular spaceA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
endoplasmic reticulum lumenA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
collagen-containing extracellular matrixA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
extracellular matrixA disintegrin and metalloproteinase with thrombospondin motifs 5Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (59)

Assay IDTitleYearJournalArticle
AID314336Inhibition of MMP22008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314340Inhibition of MMP72008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID349375Inhibition of MMP32008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID314341Inhibition of MMP82008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID344653Inhibition of pig TACE2008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID314359AUC in Sprague-Dawley rat at 8.0 mg/kg, po2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314353Oral bioavailability in Sprague-Dawley rat at 8.0 mg/kg2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314367Oral bioavailability in Beagle dog at 8.0 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314348Inhibition of ADAMTS12008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID623362Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production at 0.3 uM pretreated 15 mins before LPS challenge measured 5 hrs post LPS challenge2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Synthesis, preliminary biological evaluation and molecular modeling of some new heterocyclic inhibitors of TACE.
AID344624Inhibition of ADAMTS52008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID314368Protein binding in rat serum2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314356AUC in Sprague-Dawley rat at 5.0 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314360Half life in Beagle dog at 2.0 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314366AUC in Beagle dog at 8.0 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314342Inhibition of MMP102008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314351Inhibition of ADAM102008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314333Inhibition of semi purified pig TACE2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID349415Inhibition of MMP152008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID349377Inhibition of MMP132008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID314365Half life in Beagle dog at 8.0 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314361Clearance in Beagle dog at 2.0 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID349376Inhibition of MMP82008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID314349Inhibition of ADAMTS42008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314345Inhibition of MMP142008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314338Apparent permeability across human Caco-2 cells2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID349373Inhibition of MMP12008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID623363Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production at 1 uM pretreated 15 mins before LPS challenge measured 5 hrs post LPS challenge2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Synthesis, preliminary biological evaluation and molecular modeling of some new heterocyclic inhibitors of TACE.
AID314343Inhibition of MMP122008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314371Reduction of LPS-induced TNFalpha level in orally dosed mouse after 1 hr2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314352Clearance in Sprague-Dawley rat at 5.0 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID349414Inhibition of MMP102008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID314355Volume of distribution at steady state in Sprague-Dawley rat at 5.0 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID349385Inhibition of MMP122008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID349381Inhibition of MMP142008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID314362Volume of distribution at steady state in Beagle dog at 2.0 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID349379Inhibition of MMP92008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID314364Tmax in Beagle dog at 8.0 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314339Inhibition of MMP32008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314334Reduction of LPS-induced TNFalpha in human whole blood2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314347Inhibition of MMP162008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID344625Inhibition of ADAM102008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID314369Protein binding in dog serum2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314335Inhibition of MMP12008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314358Half life in Sprague-Dawley rat at 8.0 mg/kg, po2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID349378Inhibition of MMP72008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID314337Inhibition of MMP92008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314344Inhibition of MMP132008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314363AUC in Beagle dog at 2.0 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID349374Inhibition of MMP22008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID314354Half life in Sprague-Dawley rat at 5.0 mg/kg, iv2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314370Protein binding in human serum2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID349413Inhibition of MMP162008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID344622Inhibition of ADAMTS12008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID344623Inhibition of ADAMTS42008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
AID623364Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production pretreated 15 mins before LPS challenge measured 5 hrs post LPS challenge2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Synthesis, preliminary biological evaluation and molecular modeling of some new heterocyclic inhibitors of TACE.
AID314350Inhibition of ADAMTS52008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID314357Tmax in Sprague-Dawley rat at 8.0 mg/kg, po2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
AID1798732Enzyme Inhibition Assay from Article 10.1016/j.bmcl.2008.01.075: \\Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.\\2008Bioorganic & medicinal chemistry letters, Mar-01, Volume: 18, Issue:5
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]